Insider trading

Period: 120 months Stock: RGNX Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

25 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

25 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

25 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

25 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
25 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
25 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

25 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
23 Dec 2021
Fox Allan M. Director · indirect
Sold, plan not stated 2×
$1.79M 51,231 at 35.03
3.2%
22 Dec 2021
Fox Allan M. Director · indirect
Sold, plan not stated
$2.12M 61,638 at 34.40
3.8%
17 Sep 2021
Fox Allan M. Director · indirect
Sold, plan not stated
$2.17M 48,233 at 45.04
3.4%
14 Sep 2021
Mills Kenneth T. President and CEO
Sold, plan not stated
$1.58M 35,000 at 45.11
11.1%
23 Dec 2020
Vasista Vittal Chief Financial Officer
Sold, plan not stated
$1.06M 21,124 at 50.01
13.4%
10 Feb 2020
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$2.23M 44,429 at 50.22
81.8%
Sold half or more
10 Feb 2020
Sold, plan not stated
$1.24M 24,800 at 50.11
100%
Sold half or more
14 Jan 2020
Sold, plan not stated
$1.37M 30,000 at 45.60
100%
Sold half or more
5 Feb 2019
Simpson Curran SVP, Product Development & CTO
Sold, plan not stated
$2.20M 43,832 at 50.08
52.6%
Sold half or more
3 Dec 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 3×
$1.23M 20,414 at 60.13
100%
Sold half or more
3 Dec 2018
Mills Kenneth T. President and CEO
Sold, plan not stated 2×
$1.21M 20,000 at 60.40
8.0%
27 Nov 2018
BESHAR LUKE M Director
Sold, plan not stated
$1.22M 18,786 at 65.03
100%
Sold half or more
26 Nov 2018
Mills Kenneth T. President and CEO
Sold, plan not stated 2×
$1.28M 20,000 at 64.17
7.4%
20 Nov 2018
BESHAR LUKE M Director
Sold, plan not stated
$1.28M 21,176 at 60.38
100%
Sold half or more
19 Nov 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 6×
$1.22M 20,414 at 59.53
100%
Sold half or more
16 Nov 2018
Simpson Curran SVP, Technical Operations
Sold, plan not stated 4×
$2.10M 32,882 at 63.76
45.4%
12 Nov 2018
Mills Kenneth T. President and CEO
Sold, plan not stated 3×
$1.26M 20,000 at 63.11
6.5%
7 Nov 2018
Christmas Patrick J. SVP, General Counsel
Sold, plan not stated
$1.08M 15,000 at 72.06
84.9%
Sold half or more
5 Nov 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 5×
$1.39M 20,414 at 68.28
100%
Sold half or more
5 Nov 2018
Mills Kenneth T. President and CEO
Sold, plan not stated 5×
$1.36M 20,000 at 68.25
6.1%
2 Nov 2018
Vasista Vittal Chief Financial Officer
Sold, plan not stated
$3.78M 53,741 at 70.26
28.1%
1 Nov 2018
Vasista Vittal Chief Financial Officer
Sold, plan not stated
$1.38M 19,677 at 70.04
12.5%
29 Oct 2018
Yoo Stephen Chief Medical Officer
Sold, plan not stated 6×
$1.27M 20,414 at 62.37
100%
Sold half or more
16 Oct 2018
Simpson Curran SVP, Technical Operations
Sold, plan not stated 3×
$3.79M 62,309 at 60.85
61.2%
Sold half or more
8 Oct 2018
Danos Olivier Chief Scientific Officer
Sold, plan not stated 4×
$1.28M 20,000 at 63.80
100%
Sold half or more
Showing 1–25 of 25.